Home > Healthcare > Biotechnology > Biotechnology R&D > Serum-free Media Market

Serum-free Media Market Trends

  • Report ID: GMI6488
  • Published Date: Aug 2023
  • Report Format: PDF

Serum-free Media Market Trends

The increasing prevalence of chronic diseases has heightened the demand for serum-free media owing to their critical role in advanced research and therapeutic development. Chronic diseases often involve complex cellular interactions and intricate pathways, requiring precise and consistent cell culture environments for effective investigation. Serum-free media provide researchers a controlled and defined platform to study disease mechanisms, drug responses, and potential treatments. Furthermore, serum-free media enables the ability to eliminate the variability introduced by serum-derived components and enables to attain accurate results, thereby enhancing the credibility of findings.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The serum-free media industry accounted for USD 1.6 billion in 2022 and is estimated to grow at over 11% CAGR through 2032, backed by the increasing demand for recombinant protein products and rising stem cell research.

CHO cell culture accounted for 30.9% of the market share in 2022 and is projected to witness robust growth in coming years as CHO media offers a controlled and consistent environment for CHO cell cultivation and offers significant benefits for biopharmaceutical production.

North America market accounted for 40.4% revenue share in 2022 and is anticipated to grow at considerably through 2032, owing to the growing demand for biopharmaceutical products and rising prevalence of chronic disease.

Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Irvine Scientific, Inc., Lonza Group among others.

Serum-free Media Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 209
  • Countries covered: 18
  • Pages: 150
 Download Free Sample